Opportunistic Mold Infections 2014: Progress & Challenges (Not Official IDWeek Programming - Supported by Astellas, Merck, IMMY, MiraVista Diagnostics & MiraBella Technologies, T2 Biosystems, Inc, Viracor-IBT Laboratories - See Affiliated Event Guide)
All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the Official Program IDWeekTM 2014 are independently organized and executed. IDWeek does not endorse or support the programming of any Symposium, Presentation Theater or Learning Lounge.
Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA
Frances King Black Endowed Professor, Infectious Diseases
Deputy Head, Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Adj Professor Baylor College of Medicine
Adj Professor University of Houston
Kieren Marr, MD
Professor of Medicine and Oncology
Director, Transplant and Oncology Infectious Diseases Program
Johns Hopkins University School of Medicine
Peter Pappas, MD (Moderator)
William E. Dismukes Professor of Medicine
Principal Investigator, Mycoses Study Group
Division of Infectious Diseases
University of Alabama at Birmingham
George Thompson, MD
Associate Professor of Clinical Medicine
Department of Medical Microbiology and Immunology
Department of Medicine, Division of Infectious Diseases
UC Davis Medical Center, Sacramento California
Invasive mold infections have been identified with increased morbidity and mortality rates among hospitalized patients. Invasive fungal infections (IFIs) have also been associated with higher mortality rates. Delayed diagnosis and initiation of appropriate therapy may be a cause of these negative outcomes. This program will review the epidemiology, current and emerging diagnostic techniques, why therapy fails, current therapeutic options, and the development of novel treatment choices for improving care in patients with invasive mold infections and IFIs.
Breakfast will be served from 8:30 – 9 a.m.
Accreditation Statement— CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare. This activity has been approved for AMA PRA Category 1 Credit™. This activity is eligible for ACPE, ANCC, and AANP credit; see final CE activity announcement for specific details. Full accreditation information available atwww.akhcme.com/ID
Agenda subject to change and was provided by:
AKH Inc., Advancing Knowledge in Healthcare; PO Box 24104; Jacksonville, FL. 32241-4104; Phone: (904) 524-9931
Fax: (866) 352-6285; E-mail: firstname.lastname@example.org
Please contact Trish Brignoni directly at email@example.com.